NHS delays for hip and knee surgery are part of a wider economic problem, according to research reported by The Daily Telegraph. Longer waits are associated with more time spent claiming benefits, with orthopaedic patients accounting for the largest estimated impact. The findings strengthen the case for faster access to treatment, greater use of available hospital capacity and clearer choices for patients, including those considering private hip and knee replacement through My Medical Gateway abroad.
Britain’s NHS waiting lists are more than a measure of pressure on hospitals. They are also associated with longer periods of financial dependence, illustrating how delays in healthcare can reach into working lives and the public finances.
Reporting in The Daily Telegraph on 24 October 2026, Health Editor Laura Donnelly highlights Office for National Statistics (ONS) research linking treatment delays with an estimated 39,000 to 60,000 additional years spent claiming benefits, collectively, over a five-year period. The comparison is with the time patients would have spent receiving benefits if NHS waiting-time targets had been met.
The largest estimated impact was in trauma and orthopaedics, including hip and knee operations. Delays in this specialty were associated with 17,187 additional years of benefit receipt. General surgery accounted for another 5,485 years, while pain management accounted for 3,861.
These findings put orthopaedic waiting lists at the centre of a debate that extends beyond healthcare. Access to treatment matters to patients seeking relief and greater independence, but it also has implications for employment, household finances and the cost of supporting people unable to work.
The ONS examined patients aged 30 to 59 in England, comparing hospital treatment, waiting times and benefit claims. Receiving treatment was associated with reduced reliance on benefits for up to five years, compared with a modelled scenario without treatment. Longer waits for both inpatient and outpatient care were associated with greater benefit receipt.
The research used waiting times in 2015–16 as its benchmark, reflecting the period when the NHS last met its target of treating 92 per cent of patients within 18 weeks. That standard has remained unmet since 2016, and the treatment backlog described in the Telegraph report still exceeds seven million waits.
The findings arrive amid mounting concern about welfare spending. According to the Telegraph, expenditure on health and disability benefits is forecast to reach £90 billion this year, with the Office for Budget Responsibility expecting it to approach £110 billion by the end of the decade.
For policymakers seeking both lower spending and stronger growth, the research points towards the potential value of faster treatment. Helping people obtain appropriate care could support their health and ability to work, while easing some pressure on public finances. It is an argument for considering treatment capacity alongside employment support and welfare reform.
The Government says it is investing in surgical hubs, community diagnostics, NHS buildings and technology to accelerate care. It also points to a reduction of more than 251,000 waits since July 2024, alongside changes to benefits assessments and investment in employment support. Another part of the response is making better use of capacity already available.
This supports a practical message: patients need clear information about alternative providers and the opportunity to choose appropriate treatment sooner. Greater use of independent hospitals for NHS-funded care is one route. For those able and willing to consider self-funded treatment, accredited hospitals abroad offer another option to explore.
For someone awaiting a hip or knee operation, the immediate concern is personal. Yet the ONS findings show why improving access should also be viewed as part of the national effort to reduce prolonged dependence on state support.
This is where My Medical Gateway fits into the wider picture. MMG connects patients with accredited European hospitals offering fixed-price Treatment Packages, including hip and knee replacement. It gives people considering private surgery a structured way to compare options beyond the UK.
Patients who are unsure about proceeding can start with MMG’s free preliminary doctor consultation. Their chosen hospital can review available consultant letters and diagnostic information, explain the possible next steps and identify what further assessment is required. Preliminary advice is not clearance for surgery.
MMG cannot resolve Britain’s welfare crisis. Its contribution is to help individual patients explore access to treatment. The wider lesson of the research is that waiting carries consequences beyond the hospital: making appropriate care available sooner deserves a central place in the discussion about health, work and economic recovery.
Waiting for hip or knee surgery?
Explore fixed-price Treatment Packages at My Medical Gateway’s accredited European hospitals. If you are unsure about proceeding, start with a free preliminary doctor consultation to understand your options and take the first step towards treatment.
Leave a Reply